CI Investments Inc
MDGL icon

CI Investments Inc’s Madrigal Pharmaceuticals MDGL Stock Holding History

CI Investments Inc’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,021
Closed -$1.06M – 774
2026
Q1 		$1.06M Buy
+2,021
New +$966K 0.01% 428
2025
Q4 		– Sell
-26
Closed -$12K – 1016
2025
Q3 		$12K Sell
26
-1
-4% -$373 ﹤0.01% 1209
2025
Q2 		$8K Sell
27
-1
-4% -$298 ﹤0.01% 1246
2025
Q1 		$9K Buy
+28
New +$9.2K ﹤0.01% 1239

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CI Investments Inc's MDGL Position: Q2 2026 in Review

CI Investments Inc sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2026, closing a stake of 2,021 shares — an estimated $1.06M sold.

CI Investments Inc first reported a position in MDGL in Q1 2025 and held it in 4 quarters. The position peaked at $1.06M in Q1 2026. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • CI Investments Inc reported no remaining Madrigal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • CI Investments Inc sold 2,021 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $1.06M.
  • CI Investments Inc first reported a position in Madrigal Pharmaceuticals in Q1 2025 and held it in 4 quarters.
  • CI Investments Inc's Madrigal Pharmaceuticals position peaked at $1.06M in Q1 2026.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.